Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis and Related Disorders|January 10, 2022
Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 yearsGiulio Disanto, Marcello Moccia, Rosaria Sacco, et al.
Cephalalgia : an International Journal of Headache|May 18, 2021
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort studyAndreas R Gantenbein, Reto Agosti, Claudio Gobbi, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.
Journal of Clinical Medicine|January 28, 2026
Precision Neuromodulation Treatment Reverses Motor and Cognitive Slowing After Stroke: Clinical and Neurophysiological EvidenceGianna Carla Riccitelli, Riccardo Gironi, Edoardo Ricci, et al.
Neuroradiology|July 12, 2011
Diffusion-weighted imaging in acute demyelinating myelopathyChiara Zecca, Carlo Cereda, Stephan Wetzel, et al.
Neurology and Therapy|April 8, 2024
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple SclerosisJerome de Seze, Dominique Dive, Xavier Ayrignac, et al.
Annals of Clinical and Translational Neurology|October 18, 2023
Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathySandra Pinton, Elena Vacchi, Giacomo Chiaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2016
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigueEmanuele Pravatà, Chiara Zecca, Carlo Sestieri, et al.
Multiple Sclerosis and Related Disorders|May 30, 2020
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MSPatrick Vermersch, Jiwon Oh, Mark Cascione, et al.
Pageof 17